Clinical Report: Molecular Mechanisms of Dihuang Yinzi in Managing Diabetic Retinopathy
Overview
This study elucidates the molecular mechanisms by which Dihuang Yinzi (DHYZ) may manage diabetic retinopathy (DR), identifying key target genes, metabolites, and microbial species involved in its therapeutic effects. Findings suggest that DHYZ could influence DR through a multi-omics approach, highlighting significant biological interactions.
Background
Diabetic retinopathy is a major complication of diabetes, leading to vision loss and affecting a significant number of patients. Understanding the underlying mechanisms of DR is crucial for developing effective treatments. Traditional remedies like Dihuang Yinzi offer potential therapeutic avenues, but their mechanisms require further investigation.
Identification of 110 candidate genes related to DHYZ and DR.
Five primary target genes were highlighted: STAT3, IL6, TNF, ESR1, and IL1B.
Molecular docking revealed strong binding interactions between ESR1 and active compounds, particularly naringenin.
Metabolomic analysis identified 50 candidate metabolites relevant to DR treatment.
Microbiome assessment uncovered 24 candidate microbes associated with DHYZ's effects.
Spearman correlation analysis identified 30 key metabolites and 18 key microbes linked to therapeutic efficacy.
Clinical Implications
The findings suggest that Dihuang Yinzi may provide a multifaceted approach to managing diabetic retinopathy through its interactions with specific genes, metabolites, and microbes. Clinicians may consider integrating traditional remedies with conventional treatments to enhance therapeutic outcomes in DR.
Conclusion
This study provides valuable insights into the mechanisms of Dihuang Yinzi in diabetic retinopathy management, emphasizing the importance of a multi-omics approach in understanding traditional therapies. Further research is warranted to validate these findings in clinical settings.
